Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)UnknownNCT05074121
What this trial is testing

NAC for Attenuation of COVID-19 Symptomatology

Who this might be right for
Covid19COVID-19 PneumoniaCOVID-19 Respiratory Infection+5 more
Cambridge Health Alliance 200
Testing effectiveness (Phase 2)Study completedNCT04419025
What this trial is testing

Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease

Who this might be right for
COVIDSars-CoV2SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere+1 more
Cambridge Health Alliance 165
Large-scale testing (Phase 3)Study completedNCT04598594
What this trial is testing

Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients

Who this might be right for
Covid19SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
Assistance Publique - Hôpitaux de Paris 220
Large-scale testing (Phase 3)UnknownNCT04583410
What this trial is testing

Efficacy of Nicotine in Preventing COVID-19 Infection

Who this might be right for
Covid19SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
Assistance Publique - Hôpitaux de Paris 1,633
Testing effectiveness (Phase 2)WithdrawnNCT04459702
What this trial is testing

Combination Therapies to Treat COVID-19 Infection

Who this might be right for
COVIDCOVID-19Corona Virus Infection+5 more
ProgenaBiome
Large-scale testing (Phase 3)Study completedNCT04629703
What this trial is testing

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)SARS Pneumonia+3 more
Rigel Pharmaceuticals 280
Not applicableStudy completedNCT04339387
What this trial is testing

COVID-19 Risk Stratification

Who this might be right for
CoronavirusCoronavirus Sars-Associated as Cause of Disease Classified Elsewhere
Brigham and Women's Hospital 1,326
Large-scale testing (Phase 3)UnknownNCT04332666
What this trial is testing

Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial

Who this might be right for
CoronavirusRespiratory FailureCoronavirus Sars-Associated as Cause of Disease Classified Elsewhere+1 more
Erasme University Hospital 60
Early research (Phase 1)WithdrawnNCT04395716
What this trial is testing

ResCure™ to Treat COVID-19 Infection

Who this might be right for
COVIDCovid-19Corona Virus Infection+4 more
ProgenaBiome
Not applicableEnded earlyNCT04369989
What this trial is testing

Observational Study of COVID-19 Treatment Efficacy

Who this might be right for
CoronavirusCoronavirus InfectionCorona Virus Infection+7 more
OSF Healthcare System 250
Not applicableEnded earlyNCT04435457
What this trial is testing

Cardiovascular Implications of COVID-19

Who this might be right for
SARS-CoV 2SARS PneumoniaCOVID-19+2 more
University of Texas Southwestern Medical Center 42